Can a dengue vaccine protect our elders?
NCT ID NCT06891950
Summary
This study is testing a dengue vaccine to see if it works as well and is as safe for people aged 60 to 79 as it does for people aged 40 to 59. Researchers will compare the immune response and side effects between these two age groups over one year. The goal is to expand vaccine use to protect older adults from dengue fever.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CWB 02 - Centro Médico São Francisco
RECRUITINGCuritiba, Paraná, 80810-050, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PET 01 - Hospital Escola da Universidade de Pelotas - HEUFPEL
RECRUITINGPelotas, Rio Grande do Sul, 96040-010, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
POA 01 - Centro de Pesquisa: Hospital São Lucas - PUCRS
RECRUITINGPorto Alegre, Rio Grande do Sul, 90610-000, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
POA 02 - Associação Hospitalar Moinhos de Vento
RECRUITINGPorto Alegre, Rio Grande do Sul, 90560-032, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
POA 05 - Núcleo de Pesquisa do Rio Grande do Sul
RECRUITINGPorto Alegre, Rio Grande do Sul, 90430-001, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.